ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tofacitinib Citrate Extended-Release Tablets Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-39M17996
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Tofacitinib Citrate Extended Release Tablets Market Research Report 2024
BUY CHAPTERS

Global Tofacitinib Citrate Extended-Release Tablets Market Research Report 2024

Code: QYRE-Auto-39M17996
Report
August 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Zydus
Sino Therapeutics
Qilu Pharmaceutical
CSPC Ouyi Pharmaceutical
Yichang Humanwell Pharmaceutical
Sichuan Kelun Pharmaceutical
Lepu Pharmaceutical

Tofacitinib Citrate Extended-Release Tablets Market

Tofacitinib citrate extended-release tablets refer to a specific pharmaceutical formulation of tofacitinib citrate,a Janus kinase(JAK)inhibitor used in the treatment of certain autoimmune diseases such as rheumatoid arthritis.
The global Tofacitinib Citrate Extended-Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Tofacitinib Citrate Extended-Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tofacitinib Citrate Extended-Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tofacitinib Citrate Extended-Release Tablets include Pfizer, Zydus, Sino Therapeutics, Qilu Pharmaceutical, CSPC Ouyi Pharmaceutical, Yichang Humanwell Pharmaceutical, Sichuan Kelun Pharmaceutical, Lepu Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tofacitinib Citrate Extended-Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tofacitinib Citrate Extended-Release Tablets.
The Tofacitinib Citrate Extended-Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tofacitinib Citrate Extended-Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tofacitinib Citrate Extended-Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tofacitinib Citrate Extended-Release Tablets Market Report

Report Metric Details
Report Name Tofacitinib Citrate Extended-Release Tablets Market
Segment by Type
  • 11mg per Tablet
  • 22mg per Tablet
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Zydus, Sino Therapeutics, Qilu Pharmaceutical, CSPC Ouyi Pharmaceutical, Yichang Humanwell Pharmaceutical, Sichuan Kelun Pharmaceutical, Lepu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tofacitinib Citrate Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tofacitinib Citrate Extended-Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Tofacitinib Citrate Extended-Release Tablets Market report?

Ans: The main players in the Tofacitinib Citrate Extended-Release Tablets Market are Pfizer, Zydus, Sino Therapeutics, Qilu Pharmaceutical, CSPC Ouyi Pharmaceutical, Yichang Humanwell Pharmaceutical, Sichuan Kelun Pharmaceutical, Lepu Pharmaceutical

What are the Application segmentation covered in the Tofacitinib Citrate Extended-Release Tablets Market report?

Ans: The Applications covered in the Tofacitinib Citrate Extended-Release Tablets Market report are Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, Other

What are the Type segmentation covered in the Tofacitinib Citrate Extended-Release Tablets Market report?

Ans: The Types covered in the Tofacitinib Citrate Extended-Release Tablets Market report are 11mg per Tablet, 22mg per Tablet

Recommended Reports

Drug APIs & Tablets

Autoimmune Disease Drugs

Disease Treatments

1 Tofacitinib Citrate Extended-Release Tablets Market Overview
1.1 Product Definition
1.2 Tofacitinib Citrate Extended-Release Tablets by Type
1.2.1 Global Tofacitinib Citrate Extended-Release Tablets Market Value Comparison by Type (2024-2030)
1.2.2 11mg per Tablet
1.2.3 22mg per Tablet
1.3 Tofacitinib Citrate Extended-Release Tablets by Application
1.3.1 Global Tofacitinib Citrate Extended-Release Tablets Market Value by Application (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Psoriatic Arthritis
1.3.4 Ankylosing Spondylitis
1.3.5 Ulcerative Colitis
1.3.6 Other
1.4 Global Tofacitinib Citrate Extended-Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Tofacitinib Citrate Extended-Release Tablets Revenue 2019-2030
1.4.2 Global Tofacitinib Citrate Extended-Release Tablets Sales 2019-2030
1.4.3 Global Tofacitinib Citrate Extended-Release Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tofacitinib Citrate Extended-Release Tablets Market Competition by Manufacturers
2.1 Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tofacitinib Citrate Extended-Release Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Tofacitinib Citrate Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tofacitinib Citrate Extended-Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tofacitinib Citrate Extended-Release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Tofacitinib Citrate Extended-Release Tablets, Date of Enter into This Industry
2.8 Global Tofacitinib Citrate Extended-Release Tablets Market Competitive Situation and Trends
2.8.1 Global Tofacitinib Citrate Extended-Release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tofacitinib Citrate Extended-Release Tablets Players Market Share by Revenue
2.8.3 Global Tofacitinib Citrate Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tofacitinib Citrate Extended-Release Tablets Market Scenario by Region
3.1 Global Tofacitinib Citrate Extended-Release Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tofacitinib Citrate Extended-Release Tablets Sales by Region: 2019-2030
3.2.1 Global Tofacitinib Citrate Extended-Release Tablets Sales by Region: 2019-2024
3.2.2 Global Tofacitinib Citrate Extended-Release Tablets Sales by Region: 2025-2030
3.3 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Region: 2019-2030
3.3.1 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Region: 2019-2024
3.3.2 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Region: 2025-2030
3.4 North America Tofacitinib Citrate Extended-Release Tablets Market Facts & Figures by Country
3.4.1 North America Tofacitinib Citrate Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2030)
3.4.3 North America Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tofacitinib Citrate Extended-Release Tablets Market Facts & Figures by Country
3.5.1 Europe Tofacitinib Citrate Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2030)
3.5.3 Europe Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tofacitinib Citrate Extended-Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Tofacitinib Citrate Extended-Release Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tofacitinib Citrate Extended-Release Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Tofacitinib Citrate Extended-Release Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tofacitinib Citrate Extended-Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Tofacitinib Citrate Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2030)
3.7.3 Latin America Tofacitinib Citrate Extended-Release Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tofacitinib Citrate Extended-Release Tablets Sales by Type (2019-2030)
4.1.1 Global Tofacitinib Citrate Extended-Release Tablets Sales by Type (2019-2024)
4.1.2 Global Tofacitinib Citrate Extended-Release Tablets Sales by Type (2025-2030)
4.1.3 Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Type (2019-2030)
4.2 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Type (2019-2030)
4.2.1 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Type (2019-2024)
4.2.2 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Type (2025-2030)
4.2.3 Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Tofacitinib Citrate Extended-Release Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tofacitinib Citrate Extended-Release Tablets Sales by Application (2019-2030)
5.1.1 Global Tofacitinib Citrate Extended-Release Tablets Sales by Application (2019-2024)
5.1.2 Global Tofacitinib Citrate Extended-Release Tablets Sales by Application (2025-2030)
5.1.3 Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Application (2019-2030)
5.2 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Application (2019-2030)
5.2.1 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Application (2019-2024)
5.2.2 Global Tofacitinib Citrate Extended-Release Tablets Revenue by Application (2025-2030)
5.2.3 Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Tofacitinib Citrate Extended-Release Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Zydus
6.2.1 Zydus Company Information
6.2.2 Zydus Description and Business Overview
6.2.3 Zydus Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zydus Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.2.5 Zydus Recent Developments/Updates
6.3 Sino Therapeutics
6.3.1 Sino Therapeutics Company Information
6.3.2 Sino Therapeutics Description and Business Overview
6.3.3 Sino Therapeutics Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sino Therapeutics Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.3.5 Sino Therapeutics Recent Developments/Updates
6.4 Qilu Pharmaceutical
6.4.1 Qilu Pharmaceutical Company Information
6.4.2 Qilu Pharmaceutical Description and Business Overview
6.4.3 Qilu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qilu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.4.5 Qilu Pharmaceutical Recent Developments/Updates
6.5 CSPC Ouyi Pharmaceutical
6.5.1 CSPC Ouyi Pharmaceutical Company Information
6.5.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.5.3 CSPC Ouyi Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CSPC Ouyi Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.5.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.6 Yichang Humanwell Pharmaceutical
6.6.1 Yichang Humanwell Pharmaceutical Company Information
6.6.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.6.3 Yichang Humanwell Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yichang Humanwell Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.6.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
6.7 Sichuan Kelun Pharmaceutical
6.7.1 Sichuan Kelun Pharmaceutical Company Information
6.7.2 Sichuan Kelun Pharmaceutical Description and Business Overview
6.7.3 Sichuan Kelun Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Sichuan Kelun Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.7.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.8 Lepu Pharmaceutical
6.8.1 Lepu Pharmaceutical Company Information
6.8.2 Lepu Pharmaceutical Description and Business Overview
6.8.3 Lepu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lepu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product Portfolio
6.8.5 Lepu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tofacitinib Citrate Extended-Release Tablets Industry Chain Analysis
7.2 Tofacitinib Citrate Extended-Release Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tofacitinib Citrate Extended-Release Tablets Production Mode & Process
7.4 Tofacitinib Citrate Extended-Release Tablets Sales and Marketing
7.4.1 Tofacitinib Citrate Extended-Release Tablets Sales Channels
7.4.2 Tofacitinib Citrate Extended-Release Tablets Distributors
7.5 Tofacitinib Citrate Extended-Release Tablets Customers
8 Tofacitinib Citrate Extended-Release Tablets Market Dynamics
8.1 Tofacitinib Citrate Extended-Release Tablets Industry Trends
8.2 Tofacitinib Citrate Extended-Release Tablets Market Drivers
8.3 Tofacitinib Citrate Extended-Release Tablets Market Challenges
8.4 Tofacitinib Citrate Extended-Release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Zydus
Sino Therapeutics
Qilu Pharmaceutical
CSPC Ouyi Pharmaceutical
Yichang Humanwell Pharmaceutical
Sichuan Kelun Pharmaceutical
Lepu Pharmaceutical
List of Tables
 Table 1. Global Tofacitinib Citrate Extended-Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Tofacitinib Citrate Extended-Release Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Tofacitinib Citrate Extended-Release Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Tofacitinib Citrate Extended-Release Tablets Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Tofacitinib Citrate Extended-Release Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Tofacitinib Citrate Extended-Release Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Tofacitinib Citrate Extended-Release Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Tofacitinib Citrate Extended-Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tofacitinib Citrate Extended-Release Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tofacitinib Citrate Extended-Release Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Tofacitinib Citrate Extended-Release Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tofacitinib Citrate Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tofacitinib Citrate Extended-Release Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tofacitinib Citrate Extended-Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Tofacitinib Citrate Extended-Release Tablets Sales by Region (2019-2024) & (K Units)
 Table 18. Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Tofacitinib Citrate Extended-Release Tablets Sales by Region (2025-2030) & (K Units)
 Table 20. Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Tofacitinib Citrate Extended-Release Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Tofacitinib Citrate Extended-Release Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Tofacitinib Citrate Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
 Table 27. North America Tofacitinib Citrate Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
 Table 28. North America Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Tofacitinib Citrate Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Tofacitinib Citrate Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Tofacitinib Citrate Extended-Release Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Tofacitinib Citrate Extended-Release Tablets Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Tofacitinib Citrate Extended-Release Tablets Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Tofacitinib Citrate Extended-Release Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Tofacitinib Citrate Extended-Release Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Tofacitinib Citrate Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Tofacitinib Citrate Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Tofacitinib Citrate Extended-Release Tablets Sales (K Units) by Type (2019-2024)
 Table 51. Global Tofacitinib Citrate Extended-Release Tablets Sales (K Units) by Type (2025-2030)
 Table 52. Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Tofacitinib Citrate Extended-Release Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Tofacitinib Citrate Extended-Release Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Tofacitinib Citrate Extended-Release Tablets Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Tofacitinib Citrate Extended-Release Tablets Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Tofacitinib Citrate Extended-Release Tablets Sales (K Units) by Application (2019-2024)
 Table 61. Global Tofacitinib Citrate Extended-Release Tablets Sales (K Units) by Application (2025-2030)
 Table 62. Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Tofacitinib Citrate Extended-Release Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Tofacitinib Citrate Extended-Release Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Tofacitinib Citrate Extended-Release Tablets Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Tofacitinib Citrate Extended-Release Tablets Price (US$/Unit) by Application (2025-2030)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Pfizer Tofacitinib Citrate Extended-Release Tablets Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Zydus Company Information
 Table 76. Zydus Description and Business Overview
 Table 77. Zydus Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Zydus Tofacitinib Citrate Extended-Release Tablets Product
 Table 79. Zydus Recent Developments/Updates
 Table 80. Sino Therapeutics Company Information
 Table 81. Sino Therapeutics Description and Business Overview
 Table 82. Sino Therapeutics Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Sino Therapeutics Tofacitinib Citrate Extended-Release Tablets Product
 Table 84. Sino Therapeutics Recent Developments/Updates
 Table 85. Qilu Pharmaceutical Company Information
 Table 86. Qilu Pharmaceutical Description and Business Overview
 Table 87. Qilu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Qilu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product
 Table 89. Qilu Pharmaceutical Recent Developments/Updates
 Table 90. CSPC Ouyi Pharmaceutical Company Information
 Table 91. CSPC Ouyi Pharmaceutical Description and Business Overview
 Table 92. CSPC Ouyi Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. CSPC Ouyi Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product
 Table 94. CSPC Ouyi Pharmaceutical Recent Developments/Updates
 Table 95. Yichang Humanwell Pharmaceutical Company Information
 Table 96. Yichang Humanwell Pharmaceutical Description and Business Overview
 Table 97. Yichang Humanwell Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Yichang Humanwell Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product
 Table 99. Yichang Humanwell Pharmaceutical Recent Developments/Updates
 Table 100. Sichuan Kelun Pharmaceutical Company Information
 Table 101. Sichuan Kelun Pharmaceutical Description and Business Overview
 Table 102. Sichuan Kelun Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Sichuan Kelun Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product
 Table 104. Sichuan Kelun Pharmaceutical Recent Developments/Updates
 Table 105. Lepu Pharmaceutical Company Information
 Table 106. Lepu Pharmaceutical Description and Business Overview
 Table 107. Lepu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Lepu Pharmaceutical Tofacitinib Citrate Extended-Release Tablets Product
 Table 109. Lepu Pharmaceutical Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Tofacitinib Citrate Extended-Release Tablets Distributors List
 Table 113. Tofacitinib Citrate Extended-Release Tablets Customers List
 Table 114. Tofacitinib Citrate Extended-Release Tablets Market Trends
 Table 115. Tofacitinib Citrate Extended-Release Tablets Market Drivers
 Table 116. Tofacitinib Citrate Extended-Release Tablets Market Challenges
 Table 117. Tofacitinib Citrate Extended-Release Tablets Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tofacitinib Citrate Extended-Release Tablets
 Figure 2. Global Tofacitinib Citrate Extended-Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Tofacitinib Citrate Extended-Release Tablets Market Share by Type: 2023 & 2030
 Figure 4. 11mg per Tablet Product Picture
 Figure 5. 22mg per Tablet Product Picture
 Figure 6. Global Tofacitinib Citrate Extended-Release Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Tofacitinib Citrate Extended-Release Tablets Market Share by Application: 2023 & 2030
 Figure 8. Rheumatoid Arthritis
 Figure 9. Psoriatic Arthritis
 Figure 10. Ankylosing Spondylitis
 Figure 11. Ulcerative Colitis
 Figure 12. Other
 Figure 13. Global Tofacitinib Citrate Extended-Release Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Tofacitinib Citrate Extended-Release Tablets Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Tofacitinib Citrate Extended-Release Tablets Sales (2019-2030) & (K Units)
 Figure 16. Global Tofacitinib Citrate Extended-Release Tablets Average Price (US$/Unit) & (2019-2030)
 Figure 17. Tofacitinib Citrate Extended-Release Tablets Report Years Considered
 Figure 18. Tofacitinib Citrate Extended-Release Tablets Sales Share by Manufacturers in 2023
 Figure 19. Global Tofacitinib Citrate Extended-Release Tablets Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Tofacitinib Citrate Extended-Release Tablets Players: Market Share by Revenue in Tofacitinib Citrate Extended-Release Tablets in 2023
 Figure 21. Tofacitinib Citrate Extended-Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Tofacitinib Citrate Extended-Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Country (2019-2030)
 Figure 24. North America Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Country (2019-2030)
 Figure 25. United States Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Country (2019-2030)
 Figure 28. Europe Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Region (2019-2030)
 Figure 36. China Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Tofacitinib Citrate Extended-Release Tablets Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Tofacitinib Citrate Extended-Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Tofacitinib Citrate Extended-Release Tablets by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Tofacitinib Citrate Extended-Release Tablets by Type (2019-2030)
 Figure 55. Global Tofacitinib Citrate Extended-Release Tablets Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Tofacitinib Citrate Extended-Release Tablets by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Tofacitinib Citrate Extended-Release Tablets by Application (2019-2030)
 Figure 58. Global Tofacitinib Citrate Extended-Release Tablets Price (US$/Unit) by Application (2019-2030)
 Figure 59. Tofacitinib Citrate Extended-Release Tablets Value Chain
 Figure 60. Tofacitinib Citrate Extended-Release Tablets Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Tofacitinib Citrate Tablets Market Research Report 2024
Global Tofacitinib Citrate Market Research Report 2025
Global Tofacitinib Tablets Market Research Report 2024
Global Generic Tofacitinib Market Research Report 2025
Global Filgotinib Tablets Market Research Report 2024
Global Tofacitinib Citrate API Market Research Report 2025
Global Oral JAK Inhibitors Market Research Report 2024
Xeljanz tofacitnib Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tamoxifen Citrate Tablets Market Research Report 2024
Global Tofacitinib Market Research Report 2024
Global Baricitinib Market Research Report 2024
Global Decernotinib JAK3 Inhibitor Market Research Report 2024
Global Janus Kinase JAK Inhibitor for for Alopecia Areata Market Research Report 2025
Global Peficitinib Market Research Report 2024
Abrocitinib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ruxolitinib Drugs Market Research Report 2024
Global Calcium Citrate Tablets Market Research Report 2025
Global Tamoxifen Citrate Drugs Market Research Report 2024
Global Sorafenib Tosylate Tablets Market Research Report 2024
Global Janus Kinase JAK Inhibitors Market Insights Forecast to 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions